Our Origin
An urgent response to scarcity
When faced with an aggressive blue nevus melanoma diagnosis, our founder encountered a critical absence of scientific research, patient resources, and targeted therapies. We established this foundation to directly fund molecular oncology and build a global registry.
In close collaboration with leading oncology researchers at UCSF, we support drug repurposing studies and personalized cancer vaccine development. Our patient-led model ensures that every dollar raised directly advances clinical progress and therapeutic discovery.